A novel diagnostic marker for progressive supranuclear palsy targeting atrophy of the subthalamic nucleus. 2021

Shinsuke Fujioka, and Takashi Morishita, and Koichi Takano, and Nobutaka Takahashi, and Kanako Kurihara, and Akihiro Nishida, and Takayasu Mishima, and Midori Suenaga, and Yoichi Matsunaga, and Yoshi Tsuboi
Department of Neurology, Fukuoka University, 7-45-1, Nanakuma, Jonan-ku, Fukuoka, Japan. Electronic address: shinsuke@cis.fukuoka-u.ac.jp.

Despite great progress in radiological diagnostic tools for neurodegenerative disorders, their diagnostic accuracy has been unsatisfactory. One of the pathological hallmarks of progressive supranuclear palsy (PSP) is atrophy of the subthalamic nucleus, which has not attracted much attention for imaging analysis. The clinical data of patients with PSP, multiple system atrophy (MSA), Parkinson's disease (PD), and corticobasal syndrome (CBS) who underwent brain magnetic resonance imaging at our department between June 2019 and March 2020 were retrospectively reviewed. The volumes of the subthalamic nucleus and of the whole cerebrum were then analyzed and compared among the disorders. Fourteen PSP-Richardson syndrome (RS), 14 MSA, 14 PD, and 8 CBS patients were assessed. The mean volume of the bilateral subthalamic nuclei was smaller in PSP patients (0.148 ± 0.012 cm3) than in MSA (0.183 ± 0.026 cm3; p < 0.001), PD (0.209 ± 0.031 cm3; p < 0.001), and CBS (0.180 ± 0.056 cm3; p < 0.001) patients. The volume of the whole cerebrum was not significantly different among the disorders. Using an STN volume cut-off of 0.01925, the sensitivity and specificity for differential diagnosis between PSP and the other disorders were 0.846 and 0.972, respectively. Subthalamic nucleus volume may be a useful diagnostic marker for PSP; it may easily differentiate it from other neurodegenerative parkinsonian disorders.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001284 Atrophy Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes. Atrophies
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013494 Supranuclear Palsy, Progressive A degenerative disease of the central nervous system characterized by balance difficulties; OCULAR MOTILITY DISORDERS (supranuclear ophthalmoplegia); DYSARTHRIA; swallowing difficulties; and axial DYSTONIA. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal MESENCEPHALON; SUBTHALAMIC NUCLEUS; RED NUCLEUS; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7) Ophthalmoplegia, Progressive Supranuclear,Progressive Supranuclear Ophthalmoplegia,Progressive Supranuclear Palsy 1,Steele-Richardson-Olszewski Syndrome,Palsy, Progressive Supranuclear,Progressive Supranuclear Palsy,Richardson's Syndrome,Steele-Richardson-Olszewski Disease,Supranuclear Palsy, Progressive, 1,Progressive Supranuclear Palsies,Richardson Syndrome,Steele Richardson Olszewski Disease,Steele Richardson Olszewski Syndrome,Supranuclear Ophthalmoplegia, Progressive,Supranuclear Palsies, Progressive
D019578 Multiple System Atrophy A syndrome complex composed of three conditions which represent clinical variants of the same disease process: STRIATONIGRAL DEGENERATION; SHY-DRAGER SYNDROME; and the sporadic form of OLIVOPONTOCEREBELLAR ATROPHIES. Clinical features include autonomic, cerebellar, and basal ganglia dysfunction. Pathologic examination reveals atrophy of the basal ganglia, cerebellum, pons, and medulla, with prominent loss of autonomic neurons in the brain stem and spinal cord. (From Adams et al., Principles of Neurology, 6th ed, p1076; Baillieres Clin Neurol 1997 Apr;6(1):187-204; Med Clin North Am 1999 Mar;83(2):381-92) Multiple System Atrophy Syndrome,Multisystem Atrophy,Multisystemic Atrophy,Atrophies, Multisystem,Atrophies, Multisystemic,Atrophy, Multiple System,Atrophy, Multisystem,Atrophy, Multisystemic,Multiple System Atrophies,Multisystem Atrophies,Multisystemic Atrophies
D020531 Subthalamic Nucleus Lens-shaped structure on the inner aspect of the INTERNAL CAPSULE. The SUBTHALAMIC NUCLEUS and pathways traversing this region are concerned with the integration of somatic motor function. Nucleus Subthalamicus,Body of Luys,Corpus Luysi,Nucleus of Luys,Subthalamic Nucleus of Luys,Luys Body,Luys Nucleus,Luys Subthalamic Nucleus,Luysi, Corpus,Nucleus, Subthalamic,Subthalamicus, Nucleus

Related Publications

Shinsuke Fujioka, and Takashi Morishita, and Koichi Takano, and Nobutaka Takahashi, and Kanako Kurihara, and Akihiro Nishida, and Takayasu Mishima, and Midori Suenaga, and Yoichi Matsunaga, and Yoshi Tsuboi
February 1997, Journal of neuropathology and experimental neurology,
Shinsuke Fujioka, and Takashi Morishita, and Koichi Takano, and Nobutaka Takahashi, and Kanako Kurihara, and Akihiro Nishida, and Takayasu Mishima, and Midori Suenaga, and Yoichi Matsunaga, and Yoshi Tsuboi
August 1999, Journal of neurochemistry,
Shinsuke Fujioka, and Takashi Morishita, and Koichi Takano, and Nobutaka Takahashi, and Kanako Kurihara, and Akihiro Nishida, and Takayasu Mishima, and Midori Suenaga, and Yoichi Matsunaga, and Yoshi Tsuboi
October 2010, Revue neurologique,
Shinsuke Fujioka, and Takashi Morishita, and Koichi Takano, and Nobutaka Takahashi, and Kanako Kurihara, and Akihiro Nishida, and Takayasu Mishima, and Midori Suenaga, and Yoichi Matsunaga, and Yoshi Tsuboi
September 2003, Movement disorders : official journal of the Movement Disorder Society,
Shinsuke Fujioka, and Takashi Morishita, and Koichi Takano, and Nobutaka Takahashi, and Kanako Kurihara, and Akihiro Nishida, and Takayasu Mishima, and Midori Suenaga, and Yoichi Matsunaga, and Yoshi Tsuboi
September 1985, Ugeskrift for laeger,
Shinsuke Fujioka, and Takashi Morishita, and Koichi Takano, and Nobutaka Takahashi, and Kanako Kurihara, and Akihiro Nishida, and Takayasu Mishima, and Midori Suenaga, and Yoichi Matsunaga, and Yoshi Tsuboi
January 2015, Stereotactic and functional neurosurgery,
Shinsuke Fujioka, and Takashi Morishita, and Koichi Takano, and Nobutaka Takahashi, and Kanako Kurihara, and Akihiro Nishida, and Takayasu Mishima, and Midori Suenaga, and Yoichi Matsunaga, and Yoshi Tsuboi
February 2021, Journal of the neurological sciences,
Shinsuke Fujioka, and Takashi Morishita, and Koichi Takano, and Nobutaka Takahashi, and Kanako Kurihara, and Akihiro Nishida, and Takayasu Mishima, and Midori Suenaga, and Yoichi Matsunaga, and Yoshi Tsuboi
March 2014, Clinical neurology and neurosurgery,
Shinsuke Fujioka, and Takashi Morishita, and Koichi Takano, and Nobutaka Takahashi, and Kanako Kurihara, and Akihiro Nishida, and Takayasu Mishima, and Midori Suenaga, and Yoichi Matsunaga, and Yoshi Tsuboi
February 2011, Neuropathology : official journal of the Japanese Society of Neuropathology,
Shinsuke Fujioka, and Takashi Morishita, and Koichi Takano, and Nobutaka Takahashi, and Kanako Kurihara, and Akihiro Nishida, and Takayasu Mishima, and Midori Suenaga, and Yoichi Matsunaga, and Yoshi Tsuboi
January 2008, Journal of neurology,
Copied contents to your clipboard!